Amarin Corp Plcuk (AMRN) Free Cash Flow (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Free Cash Flow of $6.4 million for Q1 2026, up 151.27% YoY from $2.5 million in Q1 2025, and down 58.19% sequentially from $15.3 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Free Cash Flow (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Free Cash Flow across 17 years of filings, most recently posting $6.4 million for Q1 2026.

  • In Q1 2026, Free Cash Flow rose 151.27% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $25.6 million (up 182.83% YoY), while the FY2025 annual figure was $6.7 million, up 121.69% from the prior year.
  • Free Cash Flow fell to $6.4 million in Q1 2026, from $15.3 million in the prior quarter.
  • Over the last five years, Free Cash Flow for AMRN reached as high as $16.6 million in Q2 2025 and fell as low as -$98.8 million in Q1 2022.
  • The 5-year median for Free Cash Flow is -$2.7 million (2024), against an average of -$11.2 million.
  • Annual changes were most pronounced in 2024 — Free Cash Flow tumbled 1963.57% — and 2025, when it soared 704.07%.
  • A 5-year view of Free Cash Flow shows it stood at $1.6 million in 2022, then tumbled by 141.56% to -$645000.0 in 2023, then plunged by 1963.57% to -$13.3 million in 2024, then jumped by 214.79% to $15.3 million in 2025, then slumped by 58.19% to $6.4 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $6.4 million, $15.3 million, and -$12.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.01 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 1.47 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.56 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 547.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.93 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.48 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.43 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.18 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 346.00 Mn
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 6.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.39 Mn
Mar 31, 2026 6.39 Mn
Dec 31, 2025 15.28 Mn
Dec 31, 2025 15.28 Mn
Sep 30, 2025 -12.70 Mn
Sep 30, 2025 -12.70 Mn
Jun 30, 2025 16.61 Mn
Jun 30, 2025 16.61 Mn
Mar 31, 2025 -12.46 Mn
Mar 31, 2025 -12.46 Mn
Dec 31, 2024 -13.31 Mn
Dec 31, 2024 -13.31 Mn
Sep 30, 2024 -2.36 Mn
Sep 30, 2024 -2.36 Mn
Jun 30, 2024 -2.75 Mn
Jun 30, 2024 -2.75 Mn
Mar 31, 2024 -12.60 Mn
Mar 31, 2024 -12.60 Mn
Dec 31, 2023 -645,000.00
Dec 31, 2023 -645,000.00